
TNDM P/E Ratio
P/E Ratio as of Jul 3, 2025: -6.03
Average-7.11
Median-7.25
Minimum-8.06
Maximum-6.03
-6.03
Past Month+1.22 (16.83%)
The P/E ratio for TNDM is -6.03 as of Jul 3, 2025. This represents a decrease of -59.69% compared to its 12-month average P/E ratio of -14.96. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Tandem Diabetes Care P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Tandem Diabetes Care’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Tandem Diabetes Care to industry peers.
Tandem Diabetes Care P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Tandem Diabetes Care’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Tandem Diabetes Care to industry peers.
TNDM P/E Ratio Insights
See Tandem Diabetes Care’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in TNDM
Order type
Buy in
Order amount
Est. shares
0 shares
TNDM P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $17.24 | -6.19 |
Jun 2, 2025 | $20.22 | -7.26 |
May 1, 2025 | $19.98 | -13.58 |
Apr 1, 2025 | $18.73 | -12.73 |
Mar 3, 2025 | $20.78 | -14.12 |
Feb 3, 2025 | $36.40 | -18.75 |
Jan 2, 2025 | $35.84 | -18.46 |
TNDM End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -6.03 | -67.49% |
2024 | -18.55 | +102.07% |
2023 | -9.18 | -78.28% |
2022 | -42.26 | -106.56% |
2021 | 644.35 | -498.34% |
2020 | -161.76 | — |
FAQs About Tandem Diabetes Care (TNDM) P/E ratio
The latest P/E ratio of TNDM is -6.03, as of Jul 3, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Tandem Diabetes Care’s last 12-month average P/E ratio is -14.96, compared to its current P/E ratio of -6.03. This reflects a decrease of -59.69%.
Tandem Diabetes Care’s current P/E ratio of -6.03 is lower than its last 12-month average P/E of -14.96. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Tandem Diabetes Care’s average P/E ratio over the last 3 years is -30.44. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Tandem Diabetes Care’s average P/E ratio over the last 5 years is 111.46. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.